ARCHIVES

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

This article is from The Cancer Letter archive.

Vol. 19 No. 06 | February 5, 1993

Download PDF Visit The Full Archive

Related Articles

To Improve Clinical Trials Participation, Groups Plan An Awareness Campaign.

October 13, 2000

NCI Supports New Cervical Cancer Screening Guideline

January 31, 2003

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

October 9, 1981

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

In Brief: Pay raise Must Come From Intramural Funds, Not Extramural, Administration Says

May 9, 1980